Reference
Health Canada. Summary Safety Review - XALKORI (crizotinib) - Assessing the potential risk of developing a hole in the bowel (gastrointestinal perforation). Internet Document : 4 May 2017. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/xalkori-eng.php
Rights and permissions
About this article
Cite this article
Health Canada: no link with crizotinib and GI perforations. Reactions Weekly 1652, 2 (2017). https://doi.org/10.1007/s40278-017-30139-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-30139-7